Interventional nuclear medicine's contribution to molecularly targeted precision surgery.
Rev Esp Med Nucl Imagen Mol (Engl Ed)
; 41(3): 179-187, 2022.
Article
em En
| MEDLINE
| ID: mdl-35484078
ABSTRACT
The surgical approach to different pathologies, not only oncological, has evolved. As Veronesi's group has coined very graphically, we are moving from "maximum tolerable treatments to minimum effective treatments" and this journey cannot be carried out in any other way than through a multidisciplinary and multimodality approach. Multidisciplinary, because collaboration between surgeons, oncologists, radiologists, nuclear physicians, pathologists, and all those involved in patient follow-up is necessary, and multimodality, because we must move towards precision surgery tailored to each patient in which, on the part of Nuclear Medicine, hybrid imaging (SPECT/CT and PET/CT), bimodal tracers, the use of new allies such as ultrasound or our own adaptation to robotic surgery have a great deal to say. A wide range of possibilities is built on the solid foundation of preoperative scintigraphy, which makes it possible to identify the target tissues and whose knowledge prior to surgery allows the necessary surgical approach to be considered for each patient.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Procedimentos Cirúrgicos Robóticos
/
Medicina Nuclear
Limite:
Humans
Idioma:
En
Revista:
Rev Esp Med Nucl Imagen Mol (Engl Ed)
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Holanda